These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 7486872)

  • 21. ApoE polymorphism in Polish patients with Alzheimer's disease.
    Lalowski MM; Czyzewski K; Pfeffer A; Barcikowska M; Kwieciński H
    Acta Neurobiol Exp (Wars); 1998; 58(1):65-8. PubMed ID: 9583189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].
    Peng D; Xu X; Feng Y
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):688-90. PubMed ID: 11769724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.
    Steffens DC; Plassman BL; Helms MJ; Welsh-Bohmer KA; Saunders AM; Breitner JC
    Biol Psychiatry; 1997 Apr; 41(8):851-6. PubMed ID: 9099411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
    Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients.
    Scacchi R; De Bernardini L; Mantuano E; Donini LM; Vilardo T; Corbo RM
    Neurosci Lett; 1995 Dec; 201(3):231-4. PubMed ID: 8786847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease.
    Kowalska A; Florczak J; Pruchnik-Wolińska D; Kraszewski A; Wender M
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):177-81. PubMed ID: 9704150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.
    Rebeck GW; Perls TT; West HL; Sodhi P; Lipsitz LA; Hyman BT
    Neurology; 1994 Aug; 44(8):1513-6. PubMed ID: 8058160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
    Qiu C; Kivipelto M; Agüero-Torres H; Winblad B; Fratiglioni L
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):828-33. PubMed ID: 15145993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
    Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
    Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
    Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].
    Shimada K; Yasuda M; Maeda K
    Seishin Shinkeigaku Zasshi; 1997; 99(8):575-87. PubMed ID: 9369084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.
    Combarros O; García-Román M; Fontalba A; Fernández-Luna JL; Llorca J; Infante J; Berciano J
    Dement Geriatr Cogn Disord; 2003; 15(3):151-4. PubMed ID: 12584430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.
    Corder EH; Saunders AM; Risch NJ; Strittmatter WJ; Schmechel DE; Gaskell PC; Rimmler JB; Locke PA; Conneally PM; Schmader KE
    Nat Genet; 1994 Jun; 7(2):180-4. PubMed ID: 7920638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.
    DeKosky ST; Aston CE; Kamboh MI
    Ann N Y Acad Sci; 1996 Dec; 802():27-34. PubMed ID: 8993481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E polymorphism in elderly east Africans.
    Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
    East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.
    Dal Forno G; Rasmusson DX; Brandt J; Carson KA; Brookmeyer R; Troncoso J; Kawas CH
    Arch Neurol; 1996 Apr; 53(4):345-50. PubMed ID: 8929157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.